Cargando…
In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452467/ https://www.ncbi.nlm.nih.gov/pubmed/32904235 http://dx.doi.org/10.1016/j.heliyon.2020.e04720 |
_version_ | 1783575166977048576 |
---|---|
author | Kumar, Durgesh Meena, Mahendra Kumar Kumari, Kamlesh Patel, Rajan Jayaraj, Abhilash Singh, Prashant |
author_facet | Kumar, Durgesh Meena, Mahendra Kumar Kumari, Kamlesh Patel, Rajan Jayaraj, Abhilash Singh, Prashant |
author_sort | Kumar, Durgesh |
collection | PubMed |
description | Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the total screened molecules (6988) from ZINC database. Then, a one pot-three components reaction is designed to get the pyrazolophthalazine and its formation was studied using DFT method. Authors created a library of 200 compounds using the product obtained in the reaction and filtered against nsp3 of CHIKV based on docking using iGEMDOCK, a computational tool. Authors have studied the best molecules after applying the the Lipinski's rule of five and bioactive score. Further, the authors took the best compound i.e. CMPD178 and performed the MD simulations and tdMD simulations with nsp3 protease using AMBER18. MD trajectories were studied to collect the information about the nsp3 of CHIKV with and without screened compound and then, MM-GBSA calculations were performed to calculate change in binding free energies for the formation of complex. The aim of the work is to find the potential candidate as promising inhibitor against nsp3 of CHIKV. |
format | Online Article Text |
id | pubmed-7452467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74524672020-09-04 In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation Kumar, Durgesh Meena, Mahendra Kumar Kumari, Kamlesh Patel, Rajan Jayaraj, Abhilash Singh, Prashant Heliyon Article Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the total screened molecules (6988) from ZINC database. Then, a one pot-three components reaction is designed to get the pyrazolophthalazine and its formation was studied using DFT method. Authors created a library of 200 compounds using the product obtained in the reaction and filtered against nsp3 of CHIKV based on docking using iGEMDOCK, a computational tool. Authors have studied the best molecules after applying the the Lipinski's rule of five and bioactive score. Further, the authors took the best compound i.e. CMPD178 and performed the MD simulations and tdMD simulations with nsp3 protease using AMBER18. MD trajectories were studied to collect the information about the nsp3 of CHIKV with and without screened compound and then, MM-GBSA calculations were performed to calculate change in binding free energies for the formation of complex. The aim of the work is to find the potential candidate as promising inhibitor against nsp3 of CHIKV. Elsevier 2020-08-24 /pmc/articles/PMC7452467/ /pubmed/32904235 http://dx.doi.org/10.1016/j.heliyon.2020.e04720 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kumar, Durgesh Meena, Mahendra Kumar Kumari, Kamlesh Patel, Rajan Jayaraj, Abhilash Singh, Prashant In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title_full | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title_fullStr | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title_full_unstemmed | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title_short | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
title_sort | in-silico prediction of novel drug-target complex of nsp3 of chikv through molecular dynamic simulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452467/ https://www.ncbi.nlm.nih.gov/pubmed/32904235 http://dx.doi.org/10.1016/j.heliyon.2020.e04720 |
work_keys_str_mv | AT kumardurgesh insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation AT meenamahendrakumar insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation AT kumarikamlesh insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation AT patelrajan insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation AT jayarajabhilash insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation AT singhprashant insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation |